Cargando…
Prognostic Metabolite Biomarkers for Soft Tissue Sarcomas Discovered by Mass Spectrometry Imaging
Metabolites can be an important read-out of disease. The identification and validation of biomarkers in the cancer metabolome that can stratify high-risk patients is one of the main current research aspects. Mass spectrometry has become the technique of choice for metabolomics studies, and mass spec...
Autores principales: | Lou, Sha, Balluff, Benjamin, Cleven, Arjen H. G., Bovée, Judith V. M. G., McDonnell, Liam A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5227002/ https://www.ncbi.nlm.nih.gov/pubmed/27873216 http://dx.doi.org/10.1007/s13361-016-1544-4 |
Ejemplares similares
-
High nuclear expression of proteasome activator complex subunit 1 predicts poor survival in soft tissue leiomyosarcomas
por: Lou, Sha, et al.
Publicado: (2016) -
Integrative Clustering in Mass Spectrometry Imaging for Enhanced Patient Stratification
por: Balluff, Benjamin, et al.
Publicado: (2019) -
Round robin study of formalin-fixed paraffin-embedded tissues in mass spectrometry imaging
por: Buck, Achim, et al.
Publicado: (2018) -
Multiple Statistical Analysis Techniques Corroborate Intratumor Heterogeneity in Imaging Mass Spectrometry Datasets of Myxofibrosarcoma
por: Jones, Emrys A., et al.
Publicado: (2011) -
Proteomic profiling of soft tissue sarcomas with SWATH mass spectrometry
por: Milighetti, Martina, et al.
Publicado: (2021)